Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Differential regulation of myeloid leukemias by the bone marrow microenvironment.

Nature medicine | 2013

Like their normal hematopoietic stem cell counterparts, leukemia stem cells (LSCs) in chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) are presumed to reside in specific niches in the bone marrow microenvironment (BMM) and may be the cause of relapse following chemotherapy. Targeting the niche is a new strategy to eliminate persistent and drug-resistant LSCs. CD44 (refs. 3,4) and interleukin-6 (ref. 5) have been implicated previously in the LSC niche. Transforming growth factor-β1 (TGF-β1) is released during bone remodeling and plays a part in maintenance of CML LSCs, but a role for TGF-β1 from the BMM has not been defined. Here, we show that alteration of the BMM by osteoblastic cell-specific activation of the parathyroid hormone (PTH) receptor attenuates BCR-ABL1 oncogene-induced CML-like myeloproliferative neoplasia (MPN) but enhances MLL-AF9 oncogene-induced AML in mouse transplantation models, possibly through opposing effects of increased TGF-β1 on the respective LSCs. PTH treatment caused a 15-fold decrease in LSCs in wild-type mice with CML-like MPN and reduced engraftment of immune-deficient mice with primary human CML cells. These results demonstrate that LSC niches in CML and AML are distinct and suggest that modulation of the BMM by PTH may be a feasible strategy to reduce LSCs, a prerequisite for the cure of CML.

Pubmed ID: 24162813 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: U54 CA163191
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL044851
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL089747
  • Agency: NIAMS NIH HHS, United States
    Id: AR060221
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090576
  • Agency: NIA NIH HHS, United States
    Id: K01AG036744
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB014703
  • Agency: NIH HHS, United States
    Id: DP2 OD008466
  • Agency: NCI NIH HHS, United States
    Id: K08 CA138916-02
  • Agency: NIAMS NIH HHS, United States
    Id: R21AR060689
  • Agency: NIA NIH HHS, United States
    Id: K01 AG036744
  • Agency: NCI NIH HHS, United States
    Id: K08 CA138916
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009216
  • Agency: NCI NIH HHS, United States
    Id: R01 CA148180
  • Agency: NIAMS NIH HHS, United States
    Id: R21 AR060689
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR060221

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Jackson Laboratory (tool)

RRID:SCR_004633

An independent, nonprofit organization focused on mammalian genetics research to advance human health. Their mission is to discover the genetic basis for preventing, treating, and curing human disease, and to enable research for the global biomedical community. Jackson Laboratory breeds and manages colonies of mice as resources for other research institutions and laboratories, along with providing software and techniques. Jackson Lab also conducts genetic research and provides educational material for various educational levels.

View all literature mentions

Charles River Laboratories (tool)

RRID:SCR_003792

Commercial organism provider selling mice, rats and other model animals. American corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. (Wikipedia)

View all literature mentions

THP-1 (tool)

RRID:CVCL_0006

Cell line THP-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

BALB/cAnNCrl (tool)

RRID:MGI:2683685

laboratory mouse with name BALB/cAnNCrl from MGI.

View all literature mentions

K-562 (tool)

RRID:CVCL_0004

Cell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Hep 3B2.1-7 (tool)

RRID:CVCL_0326

Cell line Hep 3B2.1-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions